Cetera Investment Advisers’s Altimmune ALT Stock Holding History

Cetera Investment Advisers’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$158K	Buy	51,901 +16,448	+46%	+$49.1K	﹤0.01%	4558
2026 Q1	$109K	Buy	35,453 +5,766	+19%	+$24.5K	﹤0.01%	4427
2025 Q4	$107K	Buy	29,687 +9,481	+47%	+$41.3K	﹤0.01%	4384
2025 Q3	$76.2K	Buy	20,206 +2,056	+11%	+$7.94K	﹤0.01%	4374
2025 Q2	$70.2K	Sell	18,150 -4,652	-20%	-$25.2K	﹤0.01%	3936
2025 Q1	$114K	Buy	22,802 +8,449	+59%	+$53.5K	﹤0.01%	3749
2024 Q4	$103K	Buy	14,353 +1,270	+10%	+$9.7K	﹤0.01%	3571
2024 Q3	$80.3K	Buy	13,083 +51	+0.4%	+$346	﹤0.01%	3563
2024 Q2	$86.7K	Sell	13,032 -52,304	-80%	-$386K	﹤0.01%	3534
2024 Q1	$665K	Buy	+65,336	New	+$665K	﹤0.01%	2387

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Investment Advisers's ALT Position: Q2 2026 in Review

Cetera Investment Advisers increased its Altimmune (ALT) stake by 46% in Q2 2026, buying an estimated $49.1K and bringing the position to 51,901 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #4558.

Cetera Investment Advisers first reported a position in ALT in Q1 2024 and has held it in 10 quarters since. The position peaked at $665K in Q1 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Cetera Investment Advisers held 51,901 shares of Altimmune worth $158K as of Q2 2026.
Cetera Investment Advisers bought 16,448 Altimmune shares in Q2 2026, an estimated $49.1K.
Altimmune made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4558 holding.
Cetera Investment Advisers first reported a position in Altimmune in Q1 2024 and has held it in 10 quarters since.
Cetera Investment Advisers's Altimmune position peaked at $665K in Q1 2024.
210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.